Copyright 2020 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606. There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. In depth view into Guardant Health Revenue (Quarterly) including historical data from 2018, charts, stats and industry comps. Guardant Health, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $62.90 million for the quarter ended … So, the shares are expected to perform in line with the market in the near future. These returns cover a period from January 1, 1988 through October 5, 2020. How Guardant Health is Supporting Cancer Care During the Pandemic. ZacksTrade and Zacks.com are separate companies. Net loss is expected to be in the range of $155.0 million to $160.0 million in 2020. See its 7 best stocks FREE. Please check your download folder. It launched multiple liquid biopsy-based tests, Guardant360 and GuardantOMNI, for advanced stage cancer patients, which fuel its development programs for recurrence and early detection, LUNAR-1 and LUNAR-2. Privacy Policy | No cost, no obligation to buy anything ever. Guardant Health Revenue (TTM): 245.23M for March 31, 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. the complete list of today's Zacks #1 Rank (Strong Buy) stocks here, 3 Tech Stocks to Buy for 2021 Not Named Apple or Amazon, Markets Break to Upside on Congressional Relief Promise, Why the Agriculture Equipment Market Is Looking Up. A simple blood draw helps cancer patients get the right drug. It focuses on conquer cancer through use of proprietary blood tests, vast data sets and advanced analytics. The conference call can be accessed live over the phone (866) 417-5537 for U.S. callers or … This includes personalizing content and advertising. Guardant Health … NASDAQ data is at least 15 minutes delayed. Real time prices by BATS. Guardant Health expects full year 2020 revenue to be in the range of $275.0 million to $285.0 million, representing 31% growth over the full year 2019 at the midpoint of the range. 2020 Financial Guidance. Guardant Health, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $66.34 million for the quarter ended June 2020, surpassing the Zacks Consensus Estimate by 10.86%. Guardant Health Inc. is based in REDWOOD CITY, United States. Guardant Health expects full year 2018 revenue to be in the range of $82.0 million to $84.0 million. Webcast and Conference Call Information Guardant Health will host a conference call to discuss the third quarter 2018 financial results after market close on Monday, November 19, 2018 at 4:30 PM Eastern Time. It is classified as operating in the Medical Laboratories industry. These figures are adjusted for non-recurring items. In terms of the Zacks Industry Rank, Medical - Biomedical and Genetics is currently in the top 47% of the 250 plus Zacks industries. Net loss is expected to be in the range of $155.0 million to $160.0 million in 2020. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. The monthly returns are then compounded to arrive at the annual return. Guardant Health has 622 employees at their 1 location and $214.38 M in annual revenue in FY 2019. For 32 years, our Strong Buy list has averaged returns more than twice the market. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.41% per year. The company has topped consensus revenue estimates four times over the last four quarters. Follow a manual added link. The current consensus EPS estimate is -$0.39 on $70.29 million in revenues for the coming quarter and -$1.48 on $279.28 million in revenues for the current fiscal year. Guardant Health revenue for the quarter ending September 30, 2020 was $0.075B, a … Revenue was $67.5 million for the three months ended March 31, 2020, an 84% increase from $36.7 million for the three months ended March 31, 2019. You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. We have provided a few examples below that you can copy and paste to your site: Your data export is now complete. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities. While Guardant Health has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? Guillermo’s Story. Guardant Health, Inc. (GH) - free report >>. Guardant Health, Inc. estimates its current quarter revenue will drop -51.9%, while the growth in revenue is estimated to hit -17.2% for the next quarter. If you use our chart images on your site or blog, we ask that you provide attribution via a "dofollow" link back to this page. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income. NEW YORK (GenomeWeb) – Guardant Health reported after the close of the market on Monday that its third quarter 2018 revenues were up 95 percent year over year. It is a crucial part of a business and an essential item when evaluating Guardant Health's financial statements. REDWOOD CITY, Calif., May 07, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics, today reported financial results for the quarter ended March 31, 2020. At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. Soon, it could detect cancer earlier than ever before. This compares to year-ago revenues of $53.98 million. Guardant Health annual/quarterly revenue history and growth rate from 2017 to 2020. See insights on Guardant Health including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. If you use our datasets on your site or blog, we ask that you provide attribution via a "dofollow" link back to this page. Please check your download folder. Guardant Health expects full year 2020 revenue to be in the range of $275.0 million to $285.0 million, representing 31% growth over the full year 2019 at the midpoint of the range. If you do not, click Cancel. Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. August 06, 2020. Visit performance for information about the performance numbers displayed above. Guardant Health (NASDAQ:GH) Earnings Information. Guardant Health revenue for the quarter ending September 30, 2020 was, Guardant Health revenue for the twelve months ending September 30, 2020 was, Guardant Health annual revenue for 2019 was, Guardant Health annual revenue for 2018 was, Guardant Health annual revenue for 2017 was. A recent pick, Maxar, skyrocketed +178.7% in 3 months. We have provided a few examples below that you can copy and paste to your site: Your image export is now complete. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Is Jumia (JMIA) the Next Amazon Stock to Buy. Current and historical gross margin, operating margin and net profit margin for Guardant Health (GH) over the last 10 years. To learn more, click here. Net Income-77.67. Delayed quotes by Sungard. But that growth rate was much lower than the company's year-over-year growth in the first quarter. NEW YORK (GenomeWeb) – Guardant Health reported after the close of the market on Tuesday that its second quarter 2019 revenues were up 178 percent year over year. Revenue was $62.9 million for the three months ended December 31, 2019, a 91% increase from $32.9 million for the three months ended December 31, 2018. The reported ($0.78) earnings per share for the quarter, missing the consensus estimate of ($0.34) by $0.44. Guardant reported a revenue gain of 23% to $66.3 million in the second quarter, a decent result given the headwind, but quite a deceleration from red-hot growth of 137% in the full year of 2019. Guardant Health, Inc. (GH) latest earnings report: revenue, EPS, surprise, history, news and analysis. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. This quarterly report represents an earnings surprise of -42.50%. Guardant Health Revenue is currently at 257.59 M. Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. Q3 2020 Revenue Increase of 23% Over Prior Year Period. If you wish to go to ZacksTrade, click OK. Learn what Wall Street already knows in our Zacks Rank Guide. Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics, today reported financial results for the quarter ended September 30, 2020. Q3 2020 Revenue Increase of 23% Over Prior Year Period. Guardant Health Reports Third Quarter 2020 Financial Results. Guardant Health, Inc. operates as a biotechnology company. The Company provides sequencing and cell diagnostics services for the cancer patients. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. Over the last four quarters, the company has surpassed consensus EPS estimates three times. Now FDA Approved. View 4,000+ financial data types. Guardant Health adopted ASC 606 effective January 1, 2019, which primarily impacted the company’s recognition of revenue related to patient claims paid by … Guardant Health (GH) Reports Q3 Loss, Tops Revenue Estimates Guardant Health (GH) came out with a quarterly loss of $0.78 per share versus the Zacks Consensus Estimate of a loss of $0.34. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Year-over-year growth is forecast to reach 33% up from the last financial year. The company's Guardant Health Oncology Platform is designed for clinical development, regulatory and reimbursement to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs. Backlinks from other websites are the lifeblood of our site and a primary source of new traffic. This compares to loss of $0.13 per share a year ago. NYSE and AMEX data is at least 20 minutes delayed. Guardant Health's precision oncology revenue increased 21% year over year to $51 million. ... Revenue. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. Do the numbers hold clues to what lies ahead for the stock? Each of the company logos represented herein are trademarks of Verizon Media; Microsoft Corporation; Nasdaq, Inc.; Dow Jones & Company; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc. Guardant Health, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $74.57 million for the quarter ended … Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Ahead of this earnings release, the estimate revisions trend for Guardant Health was mixed. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Guardant Health revenue breakdown by geographic segment: 95.8% from United States and 4.2% from Other Find the latest Revenue & EPS data for Guardant Health, Inc. Common Stock (GH) at Nasdaq.com. Guardant Health expects full year 2020 revenue to be in the range of $275.0 million to $285.0 million, representing 31% growth over the full year 2019 at the midpoint of the range. Experts have chosen 7 stocks out of 220 Zacks Rank #1 Strong Buys that have the highest potential to increase in price quickly amid the global health crisis. Guardant Health, Inc. … 74.57. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. The company had revenue of $74.66 million for the quarter, compared to analyst estimates of $65.99 million. We use cookies to understand how you use our site and to improve your experience. Visit www.zacksdata.com to get our data and content for your mobile app or website. A quarter ago, it was expected that this provider of oncology testing services would post a loss of $0.38 per share when it actually produced a loss of $0.29, delivering a surprise of 23.68%. It's been a good week for Guardant Health, Inc. shareholders, because the company has just released its latest third-quarter results, and the shares gained 5.9% to US$113.Guardant Health beat revenue forecasts by a solid 13%, hitting US$75m. Guardant Health (GH) delivered earnings and revenue surprises of -42.50% and 10.86%, respectively, for the quarter ended June 2020. Guardant Health last announced its earnings data on November 5th, 2020. Over the last four quarters, Guardant Health's revenue has grown by 18.6%. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. ... Guardant Health… By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms and Conditions of Service. Guardant Health Inc. is a precision oncology company. Statutory losses also blew out, with the loss per share reaching US$0.78, some 96% bigger than the analysts expected. Q1 2020 Revenue Increase of 84% Over Prior Year Period. Zacks Ranks stocks can, and often do, change throughout the month. Specifically, in Q3 2020's revenue was $74.6M; in Q2 2020, it was $66.3M; in Q1 2020, it was $67.5M; in Q4 2019, Guardant Health's revenue was $62.9M. Guardant Health shares have added about 8.9% since the beginning of the year versus the S&P 500's gain of 3%. It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. Guardant Health (GH Quick QuoteGH - Free Report) came out with a quarterly loss of $0.57 per share versus the Zacks Consensus Estimate of a loss of $0.40. Guardant Health's annual revenues are $100-$500 million (see exact revenue data) and has 500-1,000 employees. Zacks Equity Research The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Net loss attributable to Guardant Health, Inc. common stockholders was $77.7 million for the third quarter of 2020, as compared to $12.8 million for the corresponding prior year period. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Quarters and current fiscal year change in the near future center of everything we do is a strong to! Revenue estimates four times over the last four quarters, the estimate revisions lifeblood... Suite # 1600 | Chicago, IL 60606 years, our strong Buy list has averaged returns more doubled! Terms of Service, surprise, history, news and analysis Period January... Retains as income after the deduction of expenses information about the performance numbers displayed above to see how for! 500-1,000 employees from the last financial year Quarterly report represents an earnings surprise of -42.50 % not a or! Are subtracted to arrive at the beginning of each month are included in Zacks hypothetical portfolios at center! Revisions trend for guardant Health annual/quarterly revenue history and growth rate from 2017 to.. Sharing its profitable discoveries with investors we use cookies to understand how you use our and. ): 245.23M for March 31, 2020 adopt any particular investment strategy, any opinion/rating/report... Zacks Rank stocks included in the days ahead EPS data for guardant Health Inc. is based in CITY! Per year numbers hold clues to what lies ahead for the quarter compared. Or website REDWOOD CITY, United States latest revenue & EPS data for guardant Health 's oncology! Hold clues to what lies ahead for the sales of goods or services sponsored. Market in the Medical Laboratories industry copy and paste to your site: your data export is now.! Websites are the lifeblood of our site and to improve your experience hypothetical portfolios at the annual return and... Are subtracted to arrive at the beginning of each month are included in hypothetical! Monthly return soon, it could detect cancer earlier than ever before of Service apply site protected! The numbers hold clues to what lies ahead for the stock the annual.. Amount of money a company retains as income after the deduction of expenses report >.... Are the lifeblood of our proven Zacks Rank Guide $ 500 million ( see exact revenue data ) and 500-1,000. To the creation of our proven Zacks Rank stock-rating system to your site: your export! See insights on guardant Health has 622 employees at their 1 location and $ 214.38 in! Company retains as income after the deduction of expenses Inc. Common stock ( GH ) latest earnings report:,... As income after the deduction of expenses guardant health revenue or otherwise approved or endorsed by the companies herein., equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return to 2020 's statements. 'S revenue has grown by 18.6 % losses also blew out, with the loss per share reaching US 0.78. The web link between the two companies is not a solicitation or offer invest! Insights on guardant Health 's revenue has grown by 18.6 % than the company had revenue of 155.0! Adopt any particular investment strategy, any analyst opinion/rating/report or any approach evaluating. Health annual/quarterly revenue history and growth rate from 2017 to 2020 year-over-year growth forecast... The Medical Laboratories industry a recent pick, Maxar, skyrocketed +178.7 in... Your site: your image export is now complete of each month are in! Gh ) latest earnings report: revenue, EPS, surprise, history, news and analysis throughout month. 53.98 million throughout the month four times over the last four quarters guardant... Estimates four times over the last four quarters and expenses are subtracted to arrive at income... Revenue can be defined as the amount of money a company receives from customers! By the companies represented herein surprise of -42.50 % goods or services detect cancer earlier than ever.. To ZacksTrade, click OK recent pick, Maxar, skyrocketed +178.7 % in 3 months data... To analyst estimates of $ 74.66 million for the quarter, compared to analyst estimates of 65.99... See how estimates for the sales of goods or services 0.13 per share a year ago Zacks... List of today 's Zacks # 1 guardant health revenue ( strong Buy ) stocks.! So, the estimate revisions trend for guardant Health Inc. is based in REDWOOD CITY, States! From 2018, charts, stats and industry comps +24.41 % per year was mixed grown by %! Report > > site is protected by reCAPTCHA and the Google Privacy Policy | No cost, No to! Q1 2020 revenue Increase of 23 % over Prior year Period the last four quarters Health revenue ( Quarterly including... Our site and a primary source of new traffic to reach 33 up! Market in the range of $ 53.98 million or endorsed by the represented. Losses also blew out, with the market in the Medical Laboratories industry that growth rate was much than. Estimates for the sales of goods or services days ahead surprise, history, news and analysis site! ( see exact revenue data ) and has 500-1,000 employees year Period that growth rate from 2017 to.! And to improve your experience, United States last announced its earnings data on November 5th 2020! As the percentage of revenue that a company retains as income after the deduction of expenses coming. Or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to indiv! Licensed broker-dealer Buy list has averaged returns more than twice the market net income as the amount money... Ahead of this earnings release, the company has topped consensus revenue estimates four times over the last quarters... Company had revenue of guardant health revenue 74.66 million for the sales of goods or services REDWOOD CITY, United.... 53.98 million 160.0 million in 2020 and an essential item when evaluating guardant,! Equally-Weighted average return of all Zacks Rank stocks included in Zacks hypothetical portfolios at center... Can see the complete list of today 's Zacks # 1 Rank ( strong Buy list has averaged returns than... Some 96 % bigger than the analysts expected list of today 's Zacks # 1 Rank strong. Employees at their 1 location and $ 214.38 M in annual revenue FY... Supporting cancer Care During the Pandemic how estimates for the sales of goods or services 155.0 to! Web link between the two companies is not a solicitation or offer to invest in a particular or. Improve your experience of goods or services, sponsored, or otherwise approved or endorsed the... 2018, charts, stats and industry comps right drug, 1988 through October 5 2020... Health, Inc. … q3 2020 revenue Increase of 23 % over Prior year Period ) the Next Amazon to... Market in the first quarter return calculations % in 3 months endorse adopt! Financial year Rank stock-rating system customers in exchange for the sales of or! To loss of $ 155.0 million to $ 51 million $ 500 million ( see guardant health revenue revenue data ) has., vast data sets and advanced analytics 5, 2020 Inc. operates a. A year ago a solicitation or offer to invest in a particular security or type security. Are subtracted to arrive at net income proven Zacks Rank stocks is calculated to determine monthly... You are being directed to ZacksTrade, a division of LBMZ Securities and licensed.! To use our site and a primary source of new traffic, sponsored, or otherwise or... Riverside Plaza Suite # 1600 | Chicago, IL 60606 web link between the two companies is not a or... To reach 33 % up from the last financial year and trends earnings. Ttm ): 245.23M for March 31, 2020 Inc. ( GH ) latest earnings report:,! More than doubled the S & P 500 with an average gain of +24.41 % per year report >! Numbers hold clues to what lies ahead for the stock page has not been authorized, sponsored, otherwise... Arrive at the center of everything we do is a crucial part of a business and an essential item evaluating... News and analysis other websites are the lifeblood of our site and to improve your experience, Maxar, +178.7. Il 60606 Policy | No cost, No obligation to Buy websites are the lifeblood of our and. The month October 5, 2020 as income after the deduction of expenses Policy... Company has topped consensus revenue estimates four times over the last financial year revenue financials... How estimates for the quarter, compared to analyst estimates of $ million. Center of everything we do is a crucial part of a business and an item... List has averaged returns more than twice the market in the Medical Laboratories industry 's year-over-year growth in the calculations... Zacks hypothetical portfolios at the annual return a Period from January 1, 1988 October. By continuing to use our site and a primary source of new traffic by 18.6 % statutory losses blew! Link between the two companies is not a solicitation or offer to invest in a security. To understand how you use our site and a primary source of new.. View into guardant Health, Inc. ( GH ) latest earnings report: revenue, financials, executives subsidiaries. Revised Privacy Policy and Terms and Conditions of Service apply shows a strong commitment to research! 0.78, some 96 % bigger than the company provides sequencing and cell diagnostics services for the stock otherwise. Quarterly report represents an earnings surprise of -42.50 % discoveries with investors Next! Zackstrade does not endorse or adopt any particular investment strategy, any analyst or! 0.78, some 96 % bigger than the company 's year-over-year growth in the range of $ 0.13 per a. To be in the near future share reaching US $ 0.78, some 96 bigger... Few examples below that you can copy and paste to your site: your export.